BioSpace News Archive

Healthcare Trust, Inc. (“HTI”) announced that, after careful evaluation, its board of directors strongly recommends that HTI’s stockholders reject the latest unsolicited mini-tender offer launched by MacKenzie Realty Capital, Inc. and certain of its affiliates (collectively, “MacKenzie”) to purchase up to 1,000,000 shares of HTI’s common stock

Gilead Sciences, Inc. (NASDAQ: GILD) today announced that Laura Hamill will join the company as Executive Vice President, Worldwide Commercial Operations, and will become a member of Gilead’s senior leadership team.

The U.S. District Court for the District of Alaska granted Bernie’s Pharmacy, Inc. motion for preliminary injunction, enjoining AmerisourceBergen Drug Corp. from terminating the supply of controlled substances to Bernie’s.

Completing clinical trials for the patient convenience-enhanced ‘Remsima SC’, the subcutaneous version of Remsima®, to file a Marketing Authorization Application to the European Medicines Agency

SAB Biotherapeutics, Inc. has received a $10 million investment from T. Denny Sanford as part of its Series A-2 raise.

United Spinal Association has been named a beneficiary of the Cycle For SCI fundraiser created by Ciara O’Sullivan and Larissa Clifford, who are bicycling from New York City to Orlando, Florida beginning in September to help improve the lives of individuals with spinal cord injury (SCI).

Canines-N-Kids Foundation is hosting the Paws for a Cure Research Symposium on November 12-13, 2018 at the Merck Research Laboratories in Boston to examine challenges and progress in accelerating cancer drug development for shared cancers that children and canines both get.

NFOBIONIC HAS ENTERED INTO AN EXCLUSIVE DISTRIBUTORSHIP WITH BIOTRONIK FOR MOME® KARDIA IN THE U.S.; EXPECTS SIGNIFICANT NATIONWIDE GROWTH

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that data from two Phase 1 clinical studies evaluating an extended-release (XR) formulation of its investigative drug candidate ralinepag, a next-generation, oral, selective and potent prostacyclin receptor agonist in development for the treatment of pulmonary arterial hypertension (PAH), were presented by Dr. John Adams, PhD at the European Society of Cardiology Congress on August 27.

Athletico Physical Therapy has opened a new location in Grandville on Tuesday, August 28th at 3819 Rivertown Pkwy. SW, Ste. 100, Grand Rapids, MI 49418. Athletico is looking forward to continuing its quality of care throughout the Grand Rapids area.